News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,934 Results
Type
Article (41958)
Company Profile (270)
Press Release (673693)
Multimedia
Podcasts (74)
Webinars (16)
Section
Business (205908)
Career Advice (2028)
Deals (35644)
Drug Delivery (103)
Drug Development (81756)
Employer Resources (172)
FDA (16464)
Job Trends (14992)
News (348371)
Policy (33145)
Tag
Academia (2604)
Accelerated approval (15)
Adcomms (25)
Allergies (111)
Alliances (50286)
ALS (126)
Alzheimer's disease (1532)
Antibody-drug conjugate (ADC) (172)
Approvals (16494)
Artificial intelligence (363)
Autoimmune disease (40)
Automation (23)
Bankruptcy (363)
Best Places to Work (11682)
BIOSECURE Act (21)
Biosimilars (138)
Biotechnology (186)
Bladder cancer (112)
Brain cancer (39)
Breast cancer (411)
Cancer (3315)
Cardiovascular disease (268)
Career advice (1700)
Career pathing (32)
CAR-T (205)
CDC (38)
Cell therapy (556)
Cervical cancer (27)
Clinical research (67810)
Collaboration (1189)
Company closure (4)
Compensation (832)
Complete response letters (40)
COVID-19 (2700)
CRISPR (68)
C-suite (475)
Cystic fibrosis (121)
Data (3682)
Decentralized trials (2)
Denatured (25)
Depression (80)
Diabetes (390)
Diagnostics (6522)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (165)
Drug pricing (141)
Drug shortages (28)
Duchenne muscular dystrophy (173)
Earnings (88729)
Editorial (47)
Employer branding (21)
Employer resources (148)
Events (115392)
Executive appointments (896)
FDA (18607)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1053)
Gene editing (149)
Generative AI (27)
Gene therapy (442)
GLP-1 (845)
Government (4683)
Grass and pollen (5)
Guidances (330)
Healthcare (18934)
HIV (42)
Huntington's disease (32)
IgA nephropathy (47)
Immunology and inflammation (192)
Immuno-oncology (14)
Indications (46)
Infectious disease (2895)
Inflammatory bowel disease (166)
Inflation Reduction Act (10)
Influenza (79)
Intellectual property (156)
Interviews (315)
IPO (16671)
IRA (49)
Job creations (3680)
Job search strategy (1435)
Kidney cancer (13)
Labor market (63)
Layoffs (529)
Leadership (22)
Legal (7996)
Liver cancer (84)
Longevity (11)
Lung cancer (481)
Lymphoma (242)
Machine learning (22)
Management (58)
Manufacturing (518)
MASH (107)
Medical device (13627)
Medtech (13644)
Mergers & acquisitions (19776)
Metabolic disorders (949)
Multiple sclerosis (110)
NASH (16)
Neurodegenerative disease (158)
Neuropsychiatric disorders (37)
Neuroscience (2340)
NextGen: Class of 2025 (6566)
Non-profit (4521)
Now hiring (53)
Obesity (464)
Opinion (237)
Ovarian cancer (111)
Pain (136)
Pancreatic cancer (143)
Parkinson's disease (199)
Partnered (25)
Patents (365)
Patient recruitment (260)
Peanut (55)
People (58408)
Pharmaceutical (64)
Pharmacy benefit managers (21)
Phase I (21128)
Phase II (29848)
Phase III (22236)
Pipeline (2388)
Policy (242)
Postmarket research (2580)
Preclinical (9018)
Press Release (71)
Prostate cancer (161)
Psychedelics (40)
Radiopharmaceuticals (255)
Rare diseases (535)
Real estate (6016)
Recruiting (66)
Regulatory (23479)
Reports (51)
Research institute (2374)
Resumes & cover letters (351)
Rett syndrome (12)
RNA editing (12)
RSV (56)
Schizophrenia (108)
Series A (173)
Series B (130)
Service/supplier (11)
Sickle cell disease (70)
Special edition (19)
Spinal muscular atrophy (150)
Sponsored (35)
Startups (3652)
State (2)
Stomach cancer (14)
Supply chain (86)
Tariffs (74)
The Weekly (47)
Vaccines (891)
Venture capital (59)
Weight loss (289)
Women's health (51)
Worklife (17)
Date
Today (106)
Last 7 days (425)
Last 30 days (2252)
Last 365 days (31103)
2025 (21758)
2024 (35478)
2023 (40334)
2022 (51488)
2021 (56034)
2020 (54402)
2019 (46850)
2018 (35303)
2017 (32484)
2016 (31855)
2015 (37924)
2014 (31692)
2013 (26709)
2012 (28881)
2011 (29574)
2010 (27569)
Location
Africa (738)
Alabama (69)
Alaska (7)
Arizona (258)
Arkansas (13)
Asia (39161)
Australia (6358)
California (8571)
Canada (2638)
China (781)
Colorado (358)
Connecticut (364)
Delaware (225)
Europe (84398)
Florida (1274)
Georgia (286)
Hawaii (2)
Idaho (60)
Illinois (680)
India (39)
Indiana (404)
Iowa (18)
Japan (259)
Kansas (114)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1158)
Massachusetts (6289)
Michigan (264)
Minnesota (515)
Mississippi (4)
Missouri (102)
Montana (28)
Nebraska (25)
Nevada (98)
New Hampshire (68)
New Jersey (2341)
New Mexico (28)
New York (2325)
North Carolina (1197)
North Dakota (10)
Northern California (3869)
Ohio (264)
Oklahoma (17)
Oregon (36)
Pennsylvania (1804)
Puerto Rico (17)
Rhode Island (41)
South America (1115)
South Carolina (43)
South Dakota (1)
Southern California (3303)
Tennessee (138)
Texas (1313)
United States (31230)
Utah (255)
Virginia (211)
Washington D.C. (75)
Washington State (708)
West Virginia (4)
Wisconsin (71)
715,934 Results for "adma biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
August 7, 2025
·
20 min read
Press Releases
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
July 31, 2025
·
2 min read
Press Releases
ADMA Biologics Statement on Tariffs
April 8, 2025
·
4 min read
Press Releases
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
·
20 min read
Press Releases
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
May 1, 2025
·
2 min read
Press Releases
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
April 29, 2025
·
5 min read
Press Releases
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 3, 2025
·
2 min read
Business
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, announced its first quarter 2024 financial results and provided a business update.
May 9, 2024
·
18 min read
Business
ADMA Biologics Announces CFO TransitionExecutive Search Initiated for CFO Replacement
ADMA Biologics, Inc. announced that Brian Lenz, Executive Vice President, Chief Financial Officer & General Manager, ADMA BioCenters will be transitioning from these positions to a consulting role, effective April 1, 2024.
February 28, 2024
·
4 min read
Business
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced that it will report first quarter 2024 financial results on May 9, 2024, after the U.S. financial markets close.
May 2, 2024
·
2 min read
1 of 71,594
Next
